Rifaximin Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Antibacterial drugs | Infections
Items (12m)
63
Total Quantity
714
NHS Cost
£3.3K
vs National Avg
+134.7%
MAPLE ACCESS PARTNERSHIP LLP prescribed 63 items of Rifaximin over the last 12 months at a cost of £3,312 to the NHS. This is 134.7% above the national average prescribing rate. Rifaximin is classified under Antibacterial drugs in the BNF.
Monthly Prescribing Trend
Jun 2026
3
Jun 2026
7
Jun 2026
5
Jun 2026
5
Jun 2026
4
Jun 2026
5
Jun 2026
2
Jun 2026
4
Jun 2026
8
Jun 2026
10
Jun 2026
9
Jun 2026
1
Prescribing Details
| Total Items | 63 |
|---|---|
| Total Quantity | 714 |
| Total NHS Cost | £3,312 |
| Presentations | 1 different forms |
| vs National Average | +134.7% |
Rifaximin Prescribing Comparison
| This practice | 63 items |
|---|---|
| National average per practice | 27 items |
| Difference | +134.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.